US EditionPsyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More - ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND)
Summary by Ground News
1 Articles
1 Articles
All
Left
Center
1
Right
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More - ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND)
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD A decade after it was founded as a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), MAPS Public Benefit Corporation has secured over $100 million in a Series A private stock sale. The funds will support the final stages of its application for regulatory approval to sell MDMA, also known as ecstasy, as a t…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage